Research Article
Viral Dynamic Surveillance in COVID-19 Patients: A Cohort Study
Table 1
Demographics and baseline characteristics of patients with COVID-19.
| | All patients () | Symptomatic () | Asymptomatic () | value |
| Age, years | | | | | Mean (IQR) | 38 (30-49) | 43 (34-57) | 33 (27-44) | 0·003 | Range | 85 | 85 | 53 | Sex | | | | | Female | 37 (31%) | 31 (45%) | 6 (13%) | <0·001 | Male | 81 (69%) | 39 (55%) | 42 (87%) | Races | | | | | Han | 102 | 58 | 44 | 0.2733 | Other | 16 | 12 | 4 | Occupation | | | | | Civil servant | 3 (3%) | 3 (4%) | 0 (0%) | 0·121 | Farmer | 23 (19%) | 12 (17%) | 11 (23%) | 0·376 | Worker | 6 (5%) | 4 (6%) | 2 (4%) | 0.747 | Self-employed | 8 (7%) | 6 (9%) | 2 (4%) | 0·250 | Employee | 13 (11%) | 10 (14%) | 3 (6%) | 0·097 | Student | 9 (8%) | 6 (9%) | 3 (6%) | 0·592 | Retired | 10 (8%) | 9 (13%) | 1 (2%) | 0·005 | Medical staff | 3 (3%) | 3 (4%) | 0 (0%) | 0·121 | Other | 43 (36%) | 17 (24%) | 26 (55%) | <0·001 | Comorbidities⸸ | | | | | Diabetes | 5 (4%) | 4 (6%) | 1 (2%) | 0·279 | Hypertension | 17 (14%) | 11 (16%) | 6 (13%) | 0·688 | Hyperlipidaemia | 16 (13%) | 15 (21%) | 1 (2%) | <0·001 | Liver dysfunction | 20 (17%) | 14 (20%) | 6 (13%) | 0·252 | Gastrointestinal complaints | 5 (4%) | 4 (6%) | 1 (2%) | 0·279 | Bile duct stones | 4 (3%) | 3 (4%) | 1 (2%) | 0·682 | Cardiac/cerebrovascular diseases | 6 (5%) | 4 (6%) | 2 (4%) | 0·747 | Kidney disease | 4 (3%) | 4 (6%) | 0 (0%) | 0·028 | Respiratory failure | 2 (2%) | 2 (3%) | 0 (0%) | 0·246 | Anaemia | 8 (7%) | 8 (11%) | 0 (0%) | <0·001 | Electrolyte disturbance | 10 (8%) | 7 (10%) | 3 (6%) | 0.435 | Bacterial pneumonia | 11 (9%) | 11 (16%) | 0 (0%) | <0·001 | Pulmonary tuberculosis | 3 (2%) | 3 (4%) | 1 (2%) | 0·682 | Hepatitis B virus | 4 (3%) | 2 (3%) | 2 (4%) | >0·999 |
|
|
Data are (%). ⸸Some patients had multiple comorbidities. IQR is interquartile range. |